Skip to content

Outcome of Patients After a Negative Oral Challenge to Amoxicillin

Study of Patient's Outcomes After a Negative Reintroduction Test for Amoxicillin

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04922034
Acronym
REINAD
Enrollment
190
Registered
2021-06-10
Start date
2022-01-13
Completion date
2022-07-18
Last updated
2023-09-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Negative Challenge to Amoxicillin

Keywords

penicillins, reintroduction

Brief summary

This study aims to evaluate the outcome of patients who had a negative oral challenge to Amoxicillin

Detailed description

This is a prospective, single-center, non-interventional study of patients with negative Amoxicillin oral challenge performed at Angers University Hospital between 2017 and 2019. An information letter indicating the purpose of the study is sent to eligible patients. If they do not object, patients are contacted by telephone to answer the questionnaire. This questionnaire concerns the reintroduction of penicillins at home after the challenge.

Interventions

DRUGAmoxicillin

Outcome of patients with negative oral challenge to amoxicillin

Sponsors

University Hospital, Angers
Lead SponsorOTHER_GOV

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients whith a negative challenge to Amoxicillin in the Allergology Department of the CHU of Angers between 2017 and 2019. * Major patients.

Exclusion criteria

* Poor comprehension of the French language or cognitive disorders affecting the reliability of the questionnaire * Person objecting to participate in this research and to the processing of their medical data

Design outcomes

Primary

MeasureTime frameDescription
Resumption of Amoxicillin after a negative oral challenge to AmoxicillinOral challenge test oxxuring between 2017 and 2019, and follow-up until the day of the callThe main objective is to know if patients who had a negative test for reintroduction of Amoxicillin, have resumed this molecule afterwards.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026